Back to top

Regenxbio downgraded to Equal Weight from Overweight at Barclays

Barclays analyst Eliana Merle downgraded Regenxbio (RGNX) to Equal Weight from Overweight with an unchanged price target of $12. The firm sees pote...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

REGENXBIO Inc. (RGNX)